4//SEC Filing
REATA PHARMACEUTICALS INC 4
Accession 0001209191-17-002556
CIK 0001358762operating
Filed
Jan 5, 7:00 PM ET
Accepted
Jan 6, 1:04 PM ET
Size
19.8 KB
Accession
0001209191-17-002556
Insider Transaction Report
Form 4
Bass James Edward
Director
Transactions
- Conversion
Class A common stock
2017-01-05+38,447→ 41,902 total(indirect: By Trust) - Conversion
Class B common stock
2017-01-05−38,447→ 0 total(indirect: By Trust)→ Class A common stock - Conversion
Class B common stock
2017-01-05−28,762→ 0 total→ Class A common stock - Conversion
Class B common stock
2017-01-05−16,107→ 0 total(indirect: By Trust)→ Class A common stock - Conversion
Class A common stock
2017-01-05+28,762→ 59,347 total - Conversion
Class A common stock
2017-01-05+16,107→ 17,555 total(indirect: By Trust)
Footnotes (1)
- [F1]The Class B common stock is convertible into Class A common stock on a one-for-one basis at the holder's election at any time.
Issuer
REATA PHARMACEUTICALS INC
CIK 0001358762
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001358762
Filing Metadata
- Form type
- 4
- Filed
- Jan 5, 7:00 PM ET
- Accepted
- Jan 6, 1:04 PM ET
- Size
- 19.8 KB